ImmunoGen Inc Videos

ImmunoGen Is Officially Part of AbbVie
ImmunoGen is officially part of AbbVie. Together, we'll work to help advance #cancer treatment options - aiming to disrupt the progression of this disease and offering patients more good days. Follow AbbVie for all future updates and learn more: https://bit.ly/3OF7Tdq

At the age of 27, Jess was living in Oklahoma City. She enjoyed her job at a medical research foundation but often wondered, “Is this all there is?” Jess was always dreaming of being somewhere else. Ultimately, a life-changing #ovariancancer diagnosis in 2016 would take her to places she never would have dreamed of – including the top of the world. We invite you to watch Jess’ story, called The Climb: https://bit.ly/492dtyM.

Introducing our Finance Team – a talented group of folks who serve as strategic financial partners to #TeamImmunoGen across all aspects of the business, ranging from financial planning and analysis to accounting and reporting. They ensure we can continuously innovate and develop targeted therapies to bring #moregooddays to #patients with #cancer.

Introducing Missy Richard, who has contributed three decades to #TeamImmunoGen as an Executive Assistant! Her role involves facilitating schedules, managing tasks, and ensuring efficient workflows for our Regulatory Affairs, Technical Operations, and Quality teams. We are lucky to have her on board as we work to deliver targeted therapies to #patients living with #cancer.

Our Commercial Strategy and Operations team is responsible for all things brand planning, launch readiness, marketing operations, field force effectiveness, and insights and analytics. We appreciate everything they do to bring #moregooddays to #patients with #cancer – every day. #TeamImmunoGen

Meet Dr. Fabian Zohren, #TeamImmunoGen’s new Chief Medical Officer. He brings more than two decades of experience spanning all facets of clinical research, patient care, and drug development. We are thrilled to have him on board as we seek to develop targeted therapies and deliver #moregooddays to #patients with #cancer.

Meet our Executive Director of Regulatory Affairs in Europe, Fabienne Pietravalle-Elson! Fabienne joined #TeamImmunoGen in March and is responsible for leading the execution strategy for our product pipeline in Europe, helping maximize both early and late-stage approvals of product development. We’re thankful to have Fabienne on board as we work to deliver targeted therapies to patients around the world with #cancer.

#TeamImmunoGen is lucky to have our Medical Strategy and Operations team dedicated to delivering #moregooddays to patients living with cancer. This team is responsible for driving project planning and operational excellence across our Medical Affairs landscape. Many thanks for your contributions, team!

Sometimes, things happen when you least expect it – and not for the best. Watch as Nick shares his journey from diagnosis to treatment and recovery from a rare and aggressive #bloodcancer known as #BPDCN. His story motivates everyone on #TeamImmunoGen to work unrelentingly to bring #moregooddays to people with cancer. We invite you to watch Nick’s story, called Nothing’s Promised: https://www.youtube.com/watch?v=VE027O9RJ2E #TargetABetterNow

Welcome Heather Huet! Our new CSO has a wealth of expertise in the field of ADCs. We look forward to her leadership in helping #TeamImmunoGen deliver the next generation of clinical candidates through innovative research and building our R&D organization.

Introducing our EHS and Facilities Team! These dedicated individuals work behind the scenes to keep our facilities running smoothly while supporting our workplace safety by ensuring compliance with regulations, mitigating risks, and keeping our physical space in tip-top shape. Thank you for all that you do!

We exist to interrupt the progress of #cancer so cancer can’t interrupt the lives of our #patients. This is why #BloodCancerAwareness month is important to #TeamImmunoGen – and why working relentlessly to develop targeted therapies for #BPDCN and #AML remains a top priority for our business. #TargetABetterNow #MoreGoodDays

Meet Michael Method! He’s been with #TeamImmunoGen for more than two years and is the Executive Medical Director for our solid tumor program. He leads the development and execution of our #ovariancancer clinical program, tackling strategy, protocol development, compliance, and much more. We’re grateful to have Michael help bridge the gap between scientific research and delivering targeted therapies to patients with #cancer.

Patrick Zweidler-McKay is our Executive Medical Director and has been with #TeamImmunoGen for nearly 7 years. He oversees the development of our #heme clinical programs, ensuring that the strategy and trials support the needs of patients facing high-risk blood cancers. We’re thankful for Patrick’s dedication and commitment to bringing #moregooddays to #patients with #cancer.

September is #BloodCancerAwarenessMonth - a time to honor the 1.5 million people living with or in remission from these diseases in the US. #TeamImmunoGen is proud to continue its work in #AML and #BPDCN in hopes of offering #moregooddays to #cancer #patients in need. Learn more from The Leukemia & Lymphoma Society: https://www.lls.org/.

September is #OvarianCancerAwarenessMonth. #DYK that each year, nearly 20,000 women are diagnosed with #ovariancancer in the US and just 17% will be diagnosed at an early stage. Join us in raising awareness about the disease by sharing this post so that women living with #ovariancancer can have #moregooddays. To learn more, visit Ovarian Cancer Research Alliance OCRA.

Introducing Circles Concierge as a #TeamImmunoGen perk! This personal assistance service is designed to lend a helping hand when it comes to personal and professional needs. #TeamImmunoGen can rely on Circles Concierge to do the heavy lifting, so they can focus on bringing #MoreGoodDays to #patients with #cancer.

It’s been an exciting 2+ years since Christy Fang joined #TeamImmunoGen as our Director of Regulatory Affairs. In this role, Christy acts as the direct connection between ImmunoGen and global regulatory authorities to help bring our targeted #cancer therapies to #patients across the world. We’re lucky to have her as part of our team!